methyl 3-amino-5-bromo-6-(2-pyridinyl)thieno[2,3-b]pyridine-2-carboxylate
- $524 - $756
- Product name: methyl 3-amino-5-bromo-6-(2-pyridinyl)thieno[2,3-b]pyridine-2-carboxylate
- CAS: 1092352-72-1
- MF: C14H10BrN3O2S
- MW: 364.22
- EINECS:
- MDL Number:MFCD11553053
- Synonyms:methyl 3-amino-5-bromo-6-(2-pyridinyl)thieno[2,3-b]pyridine-2-carboxylate;Thieno[2,3-b]pyridine-2-carboxylic acid, 3-amino-5-bromo-6-(2-pyridinyl)-, methyl ester
3 prices
Selected condition:
Brand
- Crysdot
- Matrix Scientific
Package
- 500mg
- 1g
- ManufacturerCrysdot
- Product numberCD11353863
- Product descriptionMethyl3-amino-5-bromo-6-(pyridin-2-yl)thieno[2,3-b]pyridine-2-carboxylate 95+%
- Packaging1g
- Price$524
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number047821
- Product descriptionMethyl 3-amino-5-bromo-6-(2-pyridinyl)thieno-[2,3-b]pyridine-2-carboxylate >95%
- Packaging500mg
- Price$599
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number047821
- Product descriptionMethyl 3-amino-5-bromo-6-(2-pyridinyl)thieno-[2,3-b]pyridine-2-carboxylate >95%
- Packaging1g
- Price$756
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Crysdot | CD11353863 | Methyl3-amino-5-bromo-6-(pyridin-2-yl)thieno[2,3-b]pyridine-2-carboxylate 95+% | 1g | $524 | 2021-12-16 | Buy |
Matrix Scientific | 047821 | Methyl 3-amino-5-bromo-6-(2-pyridinyl)thieno-[2,3-b]pyridine-2-carboxylate >95% | 500mg | $599 | 2021-12-16 | Buy |
Matrix Scientific | 047821 | Methyl 3-amino-5-bromo-6-(2-pyridinyl)thieno-[2,3-b]pyridine-2-carboxylate >95% | 1g | $756 | 2021-12-16 | Buy |
Properties
Melting point :224-226°
Boiling point :519.5±45.0 °C(Predicted)
Density :1.647±0.06 g/cm3(Predicted)
pka :0.90±0.40(Predicted)
Boiling point :519.5±45.0 °C(Predicted)
Density :1.647±0.06 g/cm3(Predicted)
pka :0.90±0.40(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|